Scheriproct Ointment 30g (S4)



Short term symptomatic relief of perianal discomfort, inflammation and itching caused by thrombosed haemorrhoids, anal fissure and pruritus ani.



  • Hypersensitivity to any of the ingredients.
  • Viral infections, primary bacterial or fungal infections in the treatment area. Secondary infections of the skin in the absence of appropriate anti-infective therapy. Known sensitivity to local anaesthetics.
  • Corticosteroids have been shown to be teratogenic in animals following dermal application. As these agents are absorbed percutaneously, teratogenicity following topical application cannot be excluded. Therefore, Scheriproct should not be used during pregnancy.
  • The excretion of effective amounts of glucocorticoid with the breast milk is improbable.


This product should not be used continuously for more than 7 days. If symptoms do not disappear quickly, discontinue treatment and consult your doctor. Certain anal disorders require specific treatment and a proctological examination. In case of bleeding, consult a doctor promptly.